We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
(-3%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Amazon
AMZN
|
+$99.5M |
| 3 |
Microsoft
MSFT
|
+$95.8M |
| 4 |
Linde
LIN
|
+$84.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$77.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$14.7M |
| 4 |
CA
CA, Inc.
CA
|
+$13.2M |
| 5 |
Clorox
CLX
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 13.08% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Consumer Staples | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Sarepta Therapeutics
SRPT
$1.66B
| $2.82M | 0.02% |
25,850
-3,451
| -12% | -$432K |
|
502
Robert Half
RHI
$3.61B
| $2.82M | 0.02% |
49,262
-92
| -0.2% | -$5.64K |
|
|
NTRI
503
DELISTED
NutriSystem, Inc.
NTRI
| $2.79M | 0.02% |
63,601
-2,453
| -4% | -$92.6K |
|
|
PARA
504
DELISTED
Paramount Global Class B
PARA
| $2.79M | 0.02% |
63,727
+26,170
| +70% | +$1.39M |
|
505
Trane Technologies
TT
$106B
| $2.78M | 0.02% |
30,521
+3,494
| +13% | +$343K |
|
|
SFLY
506
DELISTED
Shutterfly, Inc.
SFLY
| $2.78M | 0.02% |
69,029
+14,390
| +26% | +$756K |
|
507
Cboe Global Markets
CBOE
$29.8B
| $2.76M | 0.02% |
28,200
+935
| +3% | +$97.3K |
|
508
Eversource Energy
ES
$28.2B
| $2.75M | 0.02% |
42,348
+5,104
| +14% | +$333K |
|
509
Jazz Pharmaceuticals
JAZZ
$15.9B
| $2.75M | 0.02% |
22,207
-4,573
| -17% | -$678K |
|
510
Affiliated Managers Group
AMG
$9.46B
| $2.75M | 0.02% |
28,224
-491
| -2% | -$55.4K |
|
511
Ionis Pharmaceuticals
IONS
$9.35B
| $2.74M | 0.02% |
50,675
-10,154
| -17% | -$518K |
|
512
CoStar Group
CSGP
$11.3B
| $2.7M | 0.02% |
79,910
-4,110
| -5% | -$150K |
|
513
Liberty Global Class A
LBTYA
$3.31B
| $2.7M | 0.02% |
126,333
+33,493
| +36% | +$822K |
|
514
Alnylam Pharmaceuticals
ALNY
$36.3B
| $2.69M | 0.02% |
36,887
-7,327
| -17% | -$564K |
|
515
Western Union
WU
$2.57B
| $2.68M | 0.02% |
157,032
-422
| -0.3% | -$7.67K |
|
|
NFX
516
DELISTED
Newfield Exploration
NFX
| $2.64M | 0.02% |
179,948
+97,453
| +118% | +$1.96M |
|
517
AutoZone
AZO
$48.3B
| $2.63M | 0.02% |
3,139
-2,932
| -48% | -$2.35M |
|
518
News Corp Class A
NWSA
$14.5B
| $2.62M | 0.02% |
231,093
-28,589
| -11% | -$366K |
|
519
Capri Holdings
CPRI
$1.77B
| $2.58M | 0.02% |
68,010
+13,922
| +26% | +$701K |
|
520
Exelixis
EXEL
$13.9B
| $2.56M | 0.02% |
129,970
-26,702
| -17% | -$476K |
|
521
Qorvo
QRVO
$7.63B
| $2.55M | 0.02% |
41,945
+395
| +1% | +$26.6K |
|
|
SIVB
522
DELISTED
SVB Financial Group
SIVB
| $2.55M | 0.02% |
13,406
+417
| +3% | +$102K |
|
|
PRAH
523
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.54M | 0.02% |
27,612
-5,467
| -17% | -$553K |
|
524
Ralph Lauren
RL
$22.2B
| $2.53M | 0.02% |
24,491
+899
| +4% | +$106K |
|
525
Devon Energy
DVN
$51.9B
| $2.5M | 0.02% |
111,005
+839
| +0.8% | +$25.8K |
|
Similar funds
ProShare Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.
- ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
- ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
- ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
- ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
- ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
- ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
- ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.
Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.